Enterobacteriaceae references

Journal papers and conference posters

HPA Health Protection Report weekly publications are archived on the HPR site - consult the bacteraemia pages and view archived reports by year.

2006

• Elliott E, et al. In-vivo development of ertapenem resistance in a case of pneumonia caused by Klebsiella pneumoniae with an extended-spectrum beta-lactamase. Clin Infect Dis. 2006 Jun 1; 42(11):e95-8.
• Livermore DM, et al. Activity of temocillin versus prevalent ESBL- and AmpC-producing Enterobacteriaceae from SE England. J Antimicrob Chemother. 2006 May; 57(5):1012-4.
• Hope R, et al. Efficacy of practised screening methods for selection of cephalosporin-resistant Enterobacteriaceae [poster]. (PDF, 474 KB)
  
  16th ECCMID conference; 2006 Apr; Nice, France.
• Pillay DG, et al. Therapy-driven selection of carbapenem resistance in CTX-M-producing [poster]. (PDF, 851 KB)
  
  16th ECCMID conference; 2006 Apr; Nice, France.
• Sinha AK, et al. Early onset Morganella morganii sepsis in a newborn infant with emergence of cephalosporin resistance caused by derepression of Ampc beta-lactamase production. Pediatr Infect Dis J. 2006 Apr; 25(4):376-7.
• Woodford N, et al. Wide geographic spread of diverse acquired AmpC beta-lactamases in and spp. in the UK and Ireland [poster]. (PDF, 541 KB)
  
  16th ECCMID conference; 2006 Apr; Nice, France.

2005

• Ellington MJ, et al. Enterobacter spp. with qnrA are Widely Scattered among Hospitals in South-East (SE) England [poster]. (PDF, 695 KB)
  
  45th ICCAC Conference; 2005 Dec; Washington, US.
• Hope R, et al. Prevalence of Mechanisms Responsible for Cephalosporin Resistance in Enterobacteriaceae from South-East England [poster]. (PDF, 548 KB)
  
  45th ICCAC Conference; 2005 Dec; Washington, US.
• Hope R, et al. Activity of tigecycline against ESBL- AmpC- hyperproducing Enterobacteriaceae [poster]. (PDF, 340 KB)
  
  45th ICCAC Conference; 2005 Dec; Washington, US.
• Mushtaq S, et al. Activity Of Cephalosporin PPI-0903M vs. Critical Resistance Types [poster]. (PDF, 103 KB)
  
  Activity Of Cephalosporin PPI-0903M vs. Critical Resistance Types [poster]. (PDF, 103 KB)
  
  45th ICCAC Conference; 2005 Dec; Washington, US.
• Ward ME, et al. ACC-1 AmpC beta-Lactamase in and Isolates from Two Dublin Hospitals [poster]. (PDF, 542 KB)
  
  45th ICCAC Conference; 2005 Dec; Washington, US.
• Samuel JR, et al. Disagreements between disc diffusion, and MIC-based susceptibility categorizations of ertapenem versus ESBL producers. J Antimicrob Chemother. 2005 Nov; 56(5):984-5.
• Livermore DM, et al. CTX-M changing the face of ESBLs in the UK. J Antimicrob Chemother.  2005 Sep; 56(3):451-4.
• Palepou M-FI, et al. "Novel class a carbapenemase, kpc-4, in an enterobacter isolate from scotland p427 " (PDF, 546 KB)
  
  
  15th ECCMID conference; 2005 Apr; Copenhagen, Denmark.
• Ward ME, et al. "Carbapenem-resistant, ctx-m-producing klebsiella pneumoniae in the p1266 uk " (PDF, 378 KB)
  
    15th ECCMID conference; 2005 Apr; Copenhagen, Denmark.

2004

• Woodford N, et al. Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolysing class A b-lactamase, KPC-3, in a New York medical center. Antimicrob. Agents Chemother. 2004 Dec; 48(12):4793-9.
• Reynolds R, et al.; BSAC Extended Working Party on Bacteraemia Resistance Surveillance. Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance Programme. J. Antimicrob. Chemother. 2004 Jun; 53(6):1018-32.
• Essack SY, et al. Klebsiella pneumoniae isolate from South Africa with multiple TEM, SHV and AmpC beta-lactamases. Int. J. Antimicrob. Agents. 2004 Apr; 23(4):398-400.
• Mushtaq S, et al. Comparative activity of doripenem vs. Enterobacteriaceae and Acinetobacter isolates, mutants and transconjugants with characterized beta-lactamases. Antimicrob. Agents Chemother. 2004 Apr; 48(4):1313-9.
• Potz NA, et al. False-positive extended-spectrum beta-lactamase tests for Klebsiella oxytoca strains hyperproducing K1 beta-lactamase. J. Antimicrob. Chemother. 2004 Mar; 53(3):545-7.
• Johnson AP. The increasing problem of cephalosporin resistance mediated by extended-spectrum beta-lactamases. Curr Opin Investigat Drugs. 2004 Feb; 5(2):133-4.
• Livermore DM, et al. Should third-generation cephalosporins be avoided against AmpC-inducible Enterobacteriaceae? Clin. Microbiol. Infect. 2004 Jan; 10(1):84-5.

2003

• Young K, et al. "Outbreak Caused by Klebsiella pneumoniae with a New Carbapenem-Hydrolyzing Class A ??-lactamase, KPC-3 [poster]." (PDF, 103 KB)
  
  
  43rd ICAAC conference; 2003 Sep; Chicago, US.
• Livermore DM, et al. In vitro activity of piperacillin/tazobactam and other broad-spectrum antibiotics against bacteria from hospitalised patients in the British Isles. Int J Antimicrob Agents. 2003 Jul; 22(1):14-27.
• Babini GS, et al. Variable susceptibility to piperacillin/tazobactam amongst Klebsiella spp. with extended-spectrum beta-lactamases. J Antimicrob Chemother. 2003 Mar; 51(3):605-12.

2002

• Livermore DM, et al. Trends in fluoroquinolone (ciprofloxacin) resistance in enterobacteriaceae from bacteremias, England and Wales, 1990-1999. Emerging Infectious Diseases 2002; 8:473-8.